目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Technology
Market segments
Comparison by Technology
CRISPR - Market size and forecast 2020-2025
TALEN - Market size and forecast 2020-2025
ZFN - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Technology

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
CRISPR Therapeutics AG
Danaher Corp.
GenScript Biotech Corp.
Hera Biolabs Inc.
Illumina Inc.
Intellia Therapeutics Inc.
Merck KGaA
PerkinElmer Inc.
SangamTherapeutics Inc.
ThermFisher Scientific Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Technology - Market share 2020-2025 (%)
22: Comparison by Technology
23: CRISPR - Market size and forecast 2020-2025 ($ million)
24: CRISPR - Year-over-year growth 2020-2025 (%)
25: TALEN - Market size and forecast 2020-2025 ($ million)
26: TALEN - Year-over-year growth 2020-2025 (%)
27: ZFN - Market size and forecast 2020-2025 ($ million)
28: ZFN - Year-over-year growth 2020-2025 (%)
29: Others - Market size and forecast 2020-2025 ($ million)
30: Others - Year-over-year growth 2020-2025 (%)
31: Market opportunity by Technology
32: Customer landscape
33: Market share By Geographical Landscape 2020-2025 (%)
34: Geographic comparison
35: North America - Market size and forecast 2020-2025 ($ million)
36: North America - Year-over-year growth 2020-2025 (%)
37: Europe - Market size and forecast 2020-2025 ($ million)
38: Europe - Year-over-year growth 2020-2025 (%)
39: Asia - Market size and forecast 2020-2025 ($ million)
40: Asia - Year-over-year growth 2020-2025 (%)
41: ROW - Market size and forecast 2020-2025 ($ million)
42: ROW - Year-over-year growth 2020-2025 (%)
43: Key leading countries
44: Market opportunity By Geographical Landscape ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: CRISPR Therapeutics AG - Overview
52: CRISPR Therapeutics AG - Business segments
53: CRISPR Therapeutics AG - Key offerings
54: CRISPR Therapeutics AG - Key customers
55: CRISPR Therapeutics AG - Segment focus
56: Danaher Corp. - Overview
57: Danaher Corp. - Business segments
58: Danaher Corp. - Key offerings
59: Danaher Corp. - Key customers
60: Danaher Corp. - Segment focus
61: GenScript Biotech Corp. - Overview
62: GenScript Biotech Corp. - Business segments
63: GenScript Biotech Corp. - Key offerings
64: GenScript Biotech Corp. - Key customers
65: GenScript Biotech Corp. - Segment focus
66: Hera Biolabs Inc. - Overview
67: Hera Biolabs Inc. - Product and service
68: Hera Biolabs Inc. - Key offerings
69: Hera Biolabs Inc. - Key customers
70: Hera Biolabs Inc. - Segment focus
71: Illumina Inc. - Overview
72: Illumina Inc. - Product and service
73: Illumina Inc. - Key offerings
74: Illumina Inc. - Key customers
75: Illumina Inc. - Segment focus
76: Intellia Therapeutics Inc. - Overview
77: Intellia Therapeutics Inc. - Business segments
78: Intellia Therapeutics Inc. - Key offerings
79: Intellia Therapeutics Inc. - Key customers
80: Intellia Therapeutics Inc. - Segment focus
81: Merck KGaA - Overview
82: Merck KGaA - Business segments
83: Merck KGaA - Key offerings
84: Merck KGaA - Key customers
85: Merck KGaA - Segment focus
86: PerkinElmer Inc. - Overview
87: PerkinElmer Inc. - Business segments
88: PerkinElmer Inc. - Key offerings
89: PerkinElmer Inc. - Key customers
90: PerkinElmer Inc. - Segment focus
91: SangamTherapeutics Inc. - Overview
92: SangamTherapeutics Inc. - Product and service
93: SangamTherapeutics Inc. - Key offerings
94: SangamTherapeutics Inc. - Key customers
95: SangamTherapeutics Inc. - Segment focus
96: ThermFisher Scientific Inc. - Overview
97: ThermFisher Scientific Inc. - Business segments
98: ThermFisher Scientific Inc. - Key offerings
99: ThermFisher Scientific Inc. - Key customers
100: ThermFisher Scientific Inc. - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations